Selective estrogen receptor modulators, which can prevent and treat postmenopausal osteoporosis, can bind the estrogen receptor (ER) and act as ER agonists or antagonists depending on the target tissue [22]. The gene discussed is ESR1; the disease is postmenopausal osteoporosis.